Sign in

NCT05117541Completed

Social-environmental, Psychosocial, Behavioral, Clinical and Biological Drivers of Disparities in Liver Disease Progression Among Korean American With Chronic Hepatitis B Infection

Bio-psycho-social Drivers of Disparities in Liver Disease Progression Among Korean Americans With Hepatitis B Infection

Source: ClinicalTrials.gov · Last updated 22 Apr 2026

Brief summary (registry, in English)

This study explores how psychosocial factors (e.g., chronic stress, depression) may lead to liver disease progression such as liver cirrhosis or liver cancer among Korean American chronic hepatitis B infection patients. Gathering health information over time from Korean Americans with chronic hepatitis B infection may help doctors find better methods of treatment and on-going care.

Status (registry)
Completed
Study type
Observational
Enrollment
365 (actual)
First submitted
21 Sept 2021
Start date
2 Aug 2021
Primary completion date
30 Mar 2026
Lead sponsor
Thomas Jefferson University
Diseases
Hepatitis B
NCT number
NCT05117541

What you commit to

  • Study type: Observational
  • Participants enrolled: 365
  • From 2 Aug 2021 to the primary completion date, 30 Mar 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who have received a diagnosis of HCC, although they may have been diagnosed with cirrhosis

Other illness

  • Patients who have been diagnosed with other viral infections (hepatitis C virus \[HCV\], human immunodeficiency virus \[HIV\], etc.)

Other

  • Patients who have total baldness

Who the study is looking for

  • Provide signed and dated informed consent form
  • Willing to comply with all study procedures and be available for the duration of the study
  • Korean-American male or female, age over 18 and older
  • CHB Patients who have lab and medical record data (including hepatitis B virus \[HBV\] deoxyribonucleic acid \[DNA\] viral load, hepatitis B virus e Antigen \[HBeAg\] status, and liver enzyme values) exist from 2015 or before

Age in the registry: 18 years to - · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Thomas Jefferson University Hospital
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.